C3-9470. Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Monoclonal Antibody Against Ricin A Chain

Correction

In notice document 03-9470 beginning on page 18972 in the issue of Thursday, April 17, 2003, make the following corrections:

1. On page 18972, in the third column, in the second line from the bottom, “100 μg/mL”, should read “100 ηg/mL”.

2. On page 18973, in the first column, in the second line, “1000 μg/mL”, should read “1000 ηg/mL”.

Correction

In rule document 03-7322 beginning on page 16962 in the issue of Tuesday, April 8, 2003, make the following corrections:

§ 74.551

[Corrected]

1. On page 16967, in the first column, in § 74.551, in amendatory instruction 13, in the second line, “(d)” should read “(b)”.

2. On the same page, in the second column, also in §74.551, paragraph heading “(d)” should read “(b)”.

Correction

In notice document 03-9405 beginning on page 18994 in the issue of Thursday, April 17, 2003, make the following correction:

On page 18995, in the first column, under the heading DATES, in the sixth line, “May 19, 2003” should read, “June 18, 2003”.

Correction

In rule document 03-9324 beginning on page 19148 in the issue of April 18, 2003, make the following correction:

On page 19149, in the second column, under List of Subjects in 28 CFR Part 16, in the second paragraph, in the fourth line “3003” should read “2003”.

Correction

In rule document 03-9199 beginning on page 18136 in the issue of Tuesday, April 15, 2003, make the following correction:

§ 579.28

[Corrected]

On page 18143, in the second column, in §579.28, in paragraph (c), in the second line, “No” should read “(1) No”.